The role of treatment with plasma exchange therapy in two pediatric toxic epidermal necrolysis cases related to COVID‐19

Stevens‐Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life‐threatening mucocutaneous reactions characterized by necrosis and detachment of the epidermis. Drugs and bacterial or viral infections are the most common causes of SJS/TEN. Although cases of SJS/TEN have been reported afte...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical apheresis 2022-10, Vol.37 (5), p.516-521
Hauptverfasser: Varol, Fatih, Can, Yasar Yusuf, Sahin, Ebru, Durak, Cansu, Kilic, Aziz, Sahin, Ceyhan, Gursoy, Fatima, Akin, Tugba
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 521
container_issue 5
container_start_page 516
container_title Journal of clinical apheresis
container_volume 37
creator Varol, Fatih
Can, Yasar Yusuf
Sahin, Ebru
Durak, Cansu
Kilic, Aziz
Sahin, Ceyhan
Gursoy, Fatima
Akin, Tugba
description Stevens‐Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life‐threatening mucocutaneous reactions characterized by necrosis and detachment of the epidermis. Drugs and bacterial or viral infections are the most common causes of SJS/TEN. Although cases of SJS/TEN have been reported after hydroxychloroquine, vaccine (mRNA [Biontech], and inactivated vaccine [Sinovac]) administration and during the clinical course of active Coronavirus disease 2019 (COVID‐19), limited data is indicating the COVID‐19 disease as a triggering factor. Also, there are no pediatric cases of SJS/TEN associated with COVID‐19 in the literature. Herein we reported two pediatric cases with a diagnosis of TEN related to COVID‐19. Therapeutic plasma exchange therapy was applied to both of our patients. Although there are a few adult cases in the literature, our article is the first pediatric case report about patients diagnosed with TEN related to COVID‐19 and successfully treated with plasma exchange.
doi_str_mv 10.1002/jca.21997
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9350357</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2721069985</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4207-23d8664197c8e7bd5cac285cb47dd8c35d8820f285512df401033e9f9a60446d3</originalsourceid><addsrcrecordid>eNp1kc1u1DAUhS0EokNhwRtYYgOLtP5N4g1SNbRQVKmbwtby2DeNR0kcbE-n01UfgWfkSXA7FRJIbK6l689HPucg9JaSI0oIO15bc8SoUs0ztKBEtRWlhD5HC9JwXjEh1QF6ldKaEKIUly_RAZeNYryuF-juqgccwwA4dDhHMHmEKeOtzz2eB5NGg-HW9ma6Bpx7iGbeYT_hvA14BudNjt7iHG7LhNk7iKMZ8AS2SO6ST9iaBAlHGEwGV0C8vPx-_unX_U-qXqMXnRkSvHk6D9G3s9Or5Zfq4vLz-fLkorKCkaZi3LV1LahqbAvNyklrLGulXYnGudZy6dqWka6sJGWuE4QSzkF1ytREiNrxQ_RxrztvViM4W_xFM-g5-tHEnQ7G679vJt_r63CjS1akJFUE3j8JxPBjAynr0ScLw2AmCJukWd1KIRom6oK--wddh02cij3NGkZJrVQrC_VhT5WYUorQ_fkMJfqhUV0a1Y-NFvZ4z279ALv_g_rr8mT_4jfM_6Jr</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2721069985</pqid></control><display><type>article</type><title>The role of treatment with plasma exchange therapy in two pediatric toxic epidermal necrolysis cases related to COVID‐19</title><source>Wiley Journals</source><creator>Varol, Fatih ; Can, Yasar Yusuf ; Sahin, Ebru ; Durak, Cansu ; Kilic, Aziz ; Sahin, Ceyhan ; Gursoy, Fatima ; Akin, Tugba</creator><creatorcontrib>Varol, Fatih ; Can, Yasar Yusuf ; Sahin, Ebru ; Durak, Cansu ; Kilic, Aziz ; Sahin, Ceyhan ; Gursoy, Fatima ; Akin, Tugba</creatorcontrib><description>Stevens‐Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life‐threatening mucocutaneous reactions characterized by necrosis and detachment of the epidermis. Drugs and bacterial or viral infections are the most common causes of SJS/TEN. Although cases of SJS/TEN have been reported after hydroxychloroquine, vaccine (mRNA [Biontech], and inactivated vaccine [Sinovac]) administration and during the clinical course of active Coronavirus disease 2019 (COVID‐19), limited data is indicating the COVID‐19 disease as a triggering factor. Also, there are no pediatric cases of SJS/TEN associated with COVID‐19 in the literature. Herein we reported two pediatric cases with a diagnosis of TEN related to COVID‐19. Therapeutic plasma exchange therapy was applied to both of our patients. Although there are a few adult cases in the literature, our article is the first pediatric case report about patients diagnosed with TEN related to COVID‐19 and successfully treated with plasma exchange.</description><identifier>ISSN: 0733-2459</identifier><identifier>EISSN: 1098-1101</identifier><identifier>DOI: 10.1002/jca.21997</identifier><identifier>PMID: 35792366</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Apheresis ; Case Report ; Case Reports ; COVID-19 ; plasma exchange ; Skin diseases ; toxic epidermal necrolysis</subject><ispartof>Journal of clinical apheresis, 2022-10, Vol.37 (5), p.516-521</ispartof><rights>2022 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4207-23d8664197c8e7bd5cac285cb47dd8c35d8820f285512df401033e9f9a60446d3</citedby><cites>FETCH-LOGICAL-c4207-23d8664197c8e7bd5cac285cb47dd8c35d8820f285512df401033e9f9a60446d3</cites><orcidid>0000-0002-1767-1551 ; 0000-0002-2424-6887 ; 0000-0002-7532-7724 ; 0000-0003-3101-3915 ; 0000-0002-3636-1903 ; 0000-0001-6309-8859 ; 0000-0001-8994-1090 ; 0000-0003-1877-0401</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjca.21997$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjca.21997$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids></links><search><creatorcontrib>Varol, Fatih</creatorcontrib><creatorcontrib>Can, Yasar Yusuf</creatorcontrib><creatorcontrib>Sahin, Ebru</creatorcontrib><creatorcontrib>Durak, Cansu</creatorcontrib><creatorcontrib>Kilic, Aziz</creatorcontrib><creatorcontrib>Sahin, Ceyhan</creatorcontrib><creatorcontrib>Gursoy, Fatima</creatorcontrib><creatorcontrib>Akin, Tugba</creatorcontrib><title>The role of treatment with plasma exchange therapy in two pediatric toxic epidermal necrolysis cases related to COVID‐19</title><title>Journal of clinical apheresis</title><description>Stevens‐Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life‐threatening mucocutaneous reactions characterized by necrosis and detachment of the epidermis. Drugs and bacterial or viral infections are the most common causes of SJS/TEN. Although cases of SJS/TEN have been reported after hydroxychloroquine, vaccine (mRNA [Biontech], and inactivated vaccine [Sinovac]) administration and during the clinical course of active Coronavirus disease 2019 (COVID‐19), limited data is indicating the COVID‐19 disease as a triggering factor. Also, there are no pediatric cases of SJS/TEN associated with COVID‐19 in the literature. Herein we reported two pediatric cases with a diagnosis of TEN related to COVID‐19. Therapeutic plasma exchange therapy was applied to both of our patients. Although there are a few adult cases in the literature, our article is the first pediatric case report about patients diagnosed with TEN related to COVID‐19 and successfully treated with plasma exchange.</description><subject>Apheresis</subject><subject>Case Report</subject><subject>Case Reports</subject><subject>COVID-19</subject><subject>plasma exchange</subject><subject>Skin diseases</subject><subject>toxic epidermal necrolysis</subject><issn>0733-2459</issn><issn>1098-1101</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp1kc1u1DAUhS0EokNhwRtYYgOLtP5N4g1SNbRQVKmbwtby2DeNR0kcbE-n01UfgWfkSXA7FRJIbK6l689HPucg9JaSI0oIO15bc8SoUs0ztKBEtRWlhD5HC9JwXjEh1QF6ldKaEKIUly_RAZeNYryuF-juqgccwwA4dDhHMHmEKeOtzz2eB5NGg-HW9ma6Bpx7iGbeYT_hvA14BudNjt7iHG7LhNk7iKMZ8AS2SO6ST9iaBAlHGEwGV0C8vPx-_unX_U-qXqMXnRkSvHk6D9G3s9Or5Zfq4vLz-fLkorKCkaZi3LV1LahqbAvNyklrLGulXYnGudZy6dqWka6sJGWuE4QSzkF1ytREiNrxQ_RxrztvViM4W_xFM-g5-tHEnQ7G679vJt_r63CjS1akJFUE3j8JxPBjAynr0ScLw2AmCJukWd1KIRom6oK--wddh02cij3NGkZJrVQrC_VhT5WYUorQ_fkMJfqhUV0a1Y-NFvZ4z279ALv_g_rr8mT_4jfM_6Jr</recordid><startdate>202210</startdate><enddate>202210</enddate><creator>Varol, Fatih</creator><creator>Can, Yasar Yusuf</creator><creator>Sahin, Ebru</creator><creator>Durak, Cansu</creator><creator>Kilic, Aziz</creator><creator>Sahin, Ceyhan</creator><creator>Gursoy, Fatima</creator><creator>Akin, Tugba</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1767-1551</orcidid><orcidid>https://orcid.org/0000-0002-2424-6887</orcidid><orcidid>https://orcid.org/0000-0002-7532-7724</orcidid><orcidid>https://orcid.org/0000-0003-3101-3915</orcidid><orcidid>https://orcid.org/0000-0002-3636-1903</orcidid><orcidid>https://orcid.org/0000-0001-6309-8859</orcidid><orcidid>https://orcid.org/0000-0001-8994-1090</orcidid><orcidid>https://orcid.org/0000-0003-1877-0401</orcidid></search><sort><creationdate>202210</creationdate><title>The role of treatment with plasma exchange therapy in two pediatric toxic epidermal necrolysis cases related to COVID‐19</title><author>Varol, Fatih ; Can, Yasar Yusuf ; Sahin, Ebru ; Durak, Cansu ; Kilic, Aziz ; Sahin, Ceyhan ; Gursoy, Fatima ; Akin, Tugba</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4207-23d8664197c8e7bd5cac285cb47dd8c35d8820f285512df401033e9f9a60446d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Apheresis</topic><topic>Case Report</topic><topic>Case Reports</topic><topic>COVID-19</topic><topic>plasma exchange</topic><topic>Skin diseases</topic><topic>toxic epidermal necrolysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Varol, Fatih</creatorcontrib><creatorcontrib>Can, Yasar Yusuf</creatorcontrib><creatorcontrib>Sahin, Ebru</creatorcontrib><creatorcontrib>Durak, Cansu</creatorcontrib><creatorcontrib>Kilic, Aziz</creatorcontrib><creatorcontrib>Sahin, Ceyhan</creatorcontrib><creatorcontrib>Gursoy, Fatima</creatorcontrib><creatorcontrib>Akin, Tugba</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical apheresis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Varol, Fatih</au><au>Can, Yasar Yusuf</au><au>Sahin, Ebru</au><au>Durak, Cansu</au><au>Kilic, Aziz</au><au>Sahin, Ceyhan</au><au>Gursoy, Fatima</au><au>Akin, Tugba</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of treatment with plasma exchange therapy in two pediatric toxic epidermal necrolysis cases related to COVID‐19</atitle><jtitle>Journal of clinical apheresis</jtitle><date>2022-10</date><risdate>2022</risdate><volume>37</volume><issue>5</issue><spage>516</spage><epage>521</epage><pages>516-521</pages><issn>0733-2459</issn><eissn>1098-1101</eissn><abstract>Stevens‐Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life‐threatening mucocutaneous reactions characterized by necrosis and detachment of the epidermis. Drugs and bacterial or viral infections are the most common causes of SJS/TEN. Although cases of SJS/TEN have been reported after hydroxychloroquine, vaccine (mRNA [Biontech], and inactivated vaccine [Sinovac]) administration and during the clinical course of active Coronavirus disease 2019 (COVID‐19), limited data is indicating the COVID‐19 disease as a triggering factor. Also, there are no pediatric cases of SJS/TEN associated with COVID‐19 in the literature. Herein we reported two pediatric cases with a diagnosis of TEN related to COVID‐19. Therapeutic plasma exchange therapy was applied to both of our patients. Although there are a few adult cases in the literature, our article is the first pediatric case report about patients diagnosed with TEN related to COVID‐19 and successfully treated with plasma exchange.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>35792366</pmid><doi>10.1002/jca.21997</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-1767-1551</orcidid><orcidid>https://orcid.org/0000-0002-2424-6887</orcidid><orcidid>https://orcid.org/0000-0002-7532-7724</orcidid><orcidid>https://orcid.org/0000-0003-3101-3915</orcidid><orcidid>https://orcid.org/0000-0002-3636-1903</orcidid><orcidid>https://orcid.org/0000-0001-6309-8859</orcidid><orcidid>https://orcid.org/0000-0001-8994-1090</orcidid><orcidid>https://orcid.org/0000-0003-1877-0401</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0733-2459
ispartof Journal of clinical apheresis, 2022-10, Vol.37 (5), p.516-521
issn 0733-2459
1098-1101
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9350357
source Wiley Journals
subjects Apheresis
Case Report
Case Reports
COVID-19
plasma exchange
Skin diseases
toxic epidermal necrolysis
title The role of treatment with plasma exchange therapy in two pediatric toxic epidermal necrolysis cases related to COVID‐19
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T00%3A11%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20treatment%20with%20plasma%20exchange%20therapy%20in%20two%20pediatric%20toxic%20epidermal%20necrolysis%20cases%20related%20to%20COVID%E2%80%9019&rft.jtitle=Journal%20of%20clinical%20apheresis&rft.au=Varol,%20Fatih&rft.date=2022-10&rft.volume=37&rft.issue=5&rft.spage=516&rft.epage=521&rft.pages=516-521&rft.issn=0733-2459&rft.eissn=1098-1101&rft_id=info:doi/10.1002/jca.21997&rft_dat=%3Cproquest_pubme%3E2721069985%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2721069985&rft_id=info:pmid/35792366&rfr_iscdi=true